Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, Barry, Kuiken, Thijs, Herfst, Sander, Bestebroer, Theo, Lamers, Mart M., Oude Munnink, Bas B., de Meulder, Dennis, van Amerongen, Geert +16 more·2020·Science
DOI 10.1126/science.abb7314

Cited by (878)

Items 401–500 of 878

  1. Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin
    Kenneth S. Plante, Jessica A. Plante, Diana M Fernandez, Divya Mirchandani, Nathen E. Bopp, Patricia V. Aguilar, K. Jagannadha Sastry, Robert Alan Newman, Scott C. Weaver · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  2. In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus
    David Alan Winkler, Nikolai Petrovsky, Sakshi Piplani, Puneet Kumar Singh · 2020 · Figshare
  3. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals
    Su Datt Lam, Nicola Bordin, Waman, VP, Scholes, HM, Paul Ashford, Neeladri Sen, Lucy van Dorp, Clemens Rauer, Dawson, NL, Camilla Pang et al. · 2020 · UCL Discovery (University College London)
  4. A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic
    Tofael Ahmed Sumon, Md. Ashraf Hussain, Md Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S.M. Sharifuzzaman, Christopher Lyon Brown, Hyun‐Ju Kwon et al. · 2021 · Frontiers in Molecular Biosciences
  5. Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute Simian Immunodeficiency Virus Infection in a Pigtailed Macaque Model of Human Immunodeficiency Virus
    Selena M. Guerrero-Martin, Leah H. Rubin, Kirsten M. McGee, Erin N. Shirk, Suzanne E. Queen, Ming Li, Brandon T. Bullock, Bess W. Carlson, Robert J. Adams, Lúcio Gama et al. · 2021 · The Journal of Infectious Diseases
  6. Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung
    Hye Jin Shin, Keun Bon Ku, Hae Soo Kim, Hyun-Woo Moon, Gi Uk Jeong, Insu Hwang, Gun Young Yoon, Sun-Hee Lee, Sumin Lee, Dae‐Gyun Ahn et al. · 2021 · International Journal of Biological Sciences
  7. Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
    Ting-Yi Li, H. Cai, Ya-Pei Zhao, Yanfang Li, Y. Lai, H. Yao, Liu Daisy Liu, Zhou Sun, Martje Fentener van Vlissingen, T. Kuiken et al. · 2021 · EMBO Molecular Medicine
  8. SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From Other Betacoronaviruses
    Brayden G. Schindell, Meagan Allardice, Jessica A.M. McBride, Brendan Dennehy, Jason Kindrachuk · 2022 · Frontiers in Virology
  9. Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?
    Raghad Buqaileh, Hannah C. Saternos, Sidney T. Ley, A Aranda, Kathleen V. Forero, Wissam A. AbouAlaiwi · 2021 · Physiological Genomics
  10. Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
    Katarina M. Braun, Gage K. Moreno, Peter Halfmann, Emma B. Hodcroft, David A. Baker, Emma C. Boehm, Andrea M. Weiler, Amelia K. Haj, Masato Hatta, Shiho Chiba et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Time series modeling and forecasting of epidemic spreading processes using deep transfer learning
    Dong Xue, Ming Wang, Fangzhou Liu, MARTIN J. BUSS · 2024 · Chaos Solitons & Fractals
  12. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
    Mark Anthony B. Casel, Rare Rollon, Young Ki Choi · 2021 · Immune Network
  13. Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets
    Magen Ellen Francis, Brian Richardson, Una Goncin, Mara McNeil, Melissa L. Rioux, Mary K. Foley, Anni Ge, Roger D. Pechous, Jason Kindrachuk, Cheryl Cameron et al. · 2021 · Scientific Reports
  14. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
    Lisa H. Tostanoski, Lisa E. Gralinski, David R. Martinez, A. Schaefer, S. Mahrokhian, Zhen-Feng Li, Felix Nampanya, Hua-Hua Wan, Jing-You Yu, Aiquan Chang et al. · 2021 · bioRxiv
  15. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
    Rahul Kumar, Michael H. Lee, Claudia Silva Mickael, Biruk Kassa, Qadar Pasha, Rubin M. Tuder, Brian B. Graham · 2020 · ERJ Open Research
  16. Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection
    Stéphanie Longet, Jack Mellors, Miles W. Carroll, Tom Tipton · 2021 · Frontiers in Immunology
  17. Immune response to COVID-19 in older adults
    Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Janko Nikolich‐Žugich · 2021 · The Journal of Heart and Lung Transplantation
  18. SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications
    Lunzhi Yuan, Qiyi Tang, Huachen Zhu, Yi Guan, Tong Cheng, Ningshao Xia · 2021 · Emerging Microbes & Infections
  19. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
    Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, Chi‐Fei Kao, Shiu-Lok Hu, Hsiu‐Hua Ma, Jia‐Tsrong Jan, Chun‐Che Liao, Jian‐Jong Liang, Hui‐Ying Ko et al. · 2021 · PLoS ONE
  20. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
    Laure‐Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, Helena Soares, Mauro Petrillo, Maria Cristina Albertini, Nicolas Lanthier, Lucia Grenga, Maria João Amorim · 2022 · Journal of Clinical Medicine
  21. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
    Zhen Zhang, Li Zhou, Qianyun Liu, Yucheng Zheng, Xue Tan, Zhixiang Huang, Ming Sen Guo, Xin Wang, Xianying Chen, Simeng Liang et al. · 2024 · Emerging Microbes & Infections
  22. SARS-CoV-2: A New Song Recalls an Old Melody
    Kanta Subbarao · 2020 · Cell Host & Microbe
  23. Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection
    Allison L. Totura, Virginia Livingston, Ondraya M. Frick, David Dyer, D. Nichols, Aysegul Nalca · 2020 · Emerging Infectious Diseases
  24. Controversies in Tracheostomy for Patients With COVID-19: The When, Where, and How
    Stephen S Chiang, Michel B. Aboutanos, Randeep Singh Jawa, Sanjeev K Kaul, Abraham Houng, Rochelle Ami Dicker, Weidun Alan Guo · 2020 · Respiratory Care
  25. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
    Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, Carlotta Siddi, Walter Fratta, María Scherma, Paola Fadda · 2022 · Molecules
  26. Is 2020 the year when primatologists should cancel fieldwork?
    Michael J. C. Reid · 2020 · American Journal of Primatology
  27. Reverse zoonosis of coronavirus disease-19: Present status and the control by one health approach
    R. Pramod, Asha V Nair, Padmakar Tambare, Kanchana Chauhan, T. V. Kumar, R. Rajan, B. M. Mani, Muhasin Asaf, A. Pandey · 2021 · Veterinary World
  28. Role of ROCK signaling in virus replication
    Ram Kumar, Sanjay Barua, Bhupendra Nath Tripathi, Naveen Kumar · 2023 · Virus Research
  29. Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems
    Kavitha Mukund, Kalai Mathee, Shankar Subramaniam · 2020 · IEEE Open Journal of Engineering in Medicine and Biology
  30. Animal Hosts and Experimental Models of SARS-CoV-2 Infection
    Cristina Parolin, Sara Virtuoso, Marta Giovanetti, Silvia Angeletti, Massimo Ciccozzi, Alessândra Borsetti · 2021 · Chemotherapy
  31. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques
    K. V. van Rompay, K. Olstad, R. Sammak, Joseph C. Dutra, Jennifer K. Watanabe, J. Usachenko, Ramya Immareddy, A. Verma, Yashavanth Shaan Lakshmanappa, B. Schmidt et al. · 2021 · PLoS Pathogens
  32. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2
    Salma Nabil Tammam, Sara Elsafy, Shahenda Ramadan, Sita Arjune, Eva Krakor, Sanjay Mathur · 2021 · Journal of Controlled Release
  33. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review
    Sandra Runft, Iris Färber, Johannes Krüger, Nadine Krüger, Federico Armando, Cheila Rocha, Stefan Pöhlmann, Laura Burigk, Eva Leitzen, Małgorzata Ciurkiewicz et al. · 2022 · Veterinary Pathology
  34. Zebrafish models of COVID-19
    Sylwia D. Tyrkalska, Sergio Candel, Annamaria Pedoto, Diana García‐Moreno, Francisca Alcaraz‐Pérez, Álvaro Sánchez‐Ferrer, María Luisa Cayuela, Víctoriano Mulero · 2022 · FEMS Microbiology Reviews
  35. Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins
    Xianghui Liang, Xiaoyuan Chen, Junqiong Zhai, Xiaobing Li, Xu Zhang, Zhipeng Zhang, Ping Zhang, Xiao Wang, Xinyuan Cui, Hai Wang et al. · 2023 · PLoS Pathogens
  36. Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System
    Puneet Kaur Randhawa, Kaylyn R. Scanlon, Jay Rappaport, Manish Gupta · 2020 · Frontiers in Physiology
  37. The effect of coronaviruses on olfaction: systematic review
    Mislav Zugaj, N.S. van Ditzhuijzen, Korneliusz Golebski, Wytske Johanna Fokkens · 2021 · Rhinology Journal
  38. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling
    Elena I. Frolova, Oksana Palchevska, Tetyana Lukash, Francisco de Borja Pérez Domínguez, William J. Britt, Ilya V. Frolov · 2022 · Journal of Virology
  39. Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review
    Sudhanarayani S. Rao, K. Parthasarathy, Vignesh Sounderrajan, K. Neelagandan, Pradeep Anbazhagan, Vaishnavi Chandramouli · 2022 · 3 Biotech
  40. Presenting the characteristics, smoking versus diabetes, and outcome among patients hospitalized with COVID‐19
    Hassan Mohammed Abbas, Kawthar Faris Nassir, Qutaiba Ahmed Al Khames Aga, Ali Abbas Al-Gharawi, Jawad Ibrahim Rasheed, Muhammed W. Alobaidy, Adnan M. AL-Jubouri, Ali Habeeb Jaber, Luma Ahmed Al Khames Aga · 2020 · Journal of Medical Virology
  41. Non-human Primate Determinants of Natural Killer Cells in Tissues at Steady-State and During Simian Immunodeficiency Virus Infection
    Nicolas Huot, Philippe Rascle, Caroline Petitdemange, Vanessa Contreras, Jean‐Louis Palgen, Christiane Stahl‐Hennig, Roger Le Grand, Anne‐Sophie Beignon, Béatrice Jacquelin, Michaela C. Müller-Trutwin · 2020 · Frontiers in Immunology
  42. COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2
    Rajesh Kumar, Seetha Harilal, Abdullah Godran Al-Sehemi, Mehboobali Pannipara, Tapan Behl, Githa Elizabeth Mathew, Bijo Mathew · 2020 · Current Pharmaceutical Design
  43. Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls
    Bhanu Prasad Venkatesulu, Scott C. Lester, Rodney Cheng-En Hsieh, Vivek Verma, Elad Sharon, Mansoor M. Ahmed, Sunil Krishnan · 2020 · JNCI Cancer Spectrum
  44. A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
    Esther Shuyi Gan, Ayesa Syenina, Martin Linster, Benson Ng, Summer Li-Xin Zhang, Satoru Watanabe, Ravisankar Rajarethinam, Hwee Cheng Tan, Gavin J. D. Smith, Eng Eong Ooi · 2021 · Antiviral Research
  45. Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters
    Bryan D. Griffin, Bryce M. Warner, Mable Chan, Emelissa J. Valcourt, Nikesh Tailor, Logan Banadyga, Anders Leung, Shihua He, Amrit S. Boese, Jonathan Audet et al. · 2021 · iScience
  46. The urgency of wider adoption of one health approach for the prevention of a future pandemic
    M. Nazmul Hoque, Golam Mahbub Faisal, Farhan Rahman Chowdhury, Amlan Haque, Tofazzal Islam · 2022 · International Journal of One Health
  47. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease
    Alexandra Melton, Lara A. Doyle‐Meyers, Robert V. Blair, Cecily C. Midkiff, Hunter J. Melton, Kasi Russell‐Lodrigue, Pyone P. Aye, Faith R. Schiro, Marissa D. Fahlberg, Dawn M. Szeltner et al. · 2021 · PLoS Pathogens
  48. An Overview of SARS‐CoV‐2 and Animal Infection
    Mohamed A. A. Mahdy · 2020 · Preprints.org
  49. Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig
    Peter M. H. Heegaard, Michael S. Sturek, Mouhamad Alloosh, Graham J. Belsham · 2020 · Frontiers in Microbiology
  50. A dependency-based machine learning approach to the identification of research topics: a case in COVID-19 studies
    Haoran Zhu, Lei Lei · 2021 · Library Hi Tech
  51. Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques
    Thalia Rodriguez, Hana M. Dobrovolny · 2021 · Royal Society Open Science
  52. Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients
    Shikha Chaudhary, Ravi Prakash Yadav, Shailendra Kumar, Subhash Chandra Yadav · 2023 · Virology Journal
  53. Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles
    Mervat E. Hamdy, Ayman H. El‐Deeb, Naglaa Mohammed Hagag, Momtaz Abdelhady Shahein, Osama Alaidi, Hussein A. Hussein · 2023 · International Journal of Veterinary Science and Medicine
  54. SARS-CoV-2: Outline, Prevention, and Decontamination
    Edyta Janik, Maciej Bartos, Marcin Niemcewicz, Leslaw Gorniak, Michał Bijak · 2021 · Pathogens
  55. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
    Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, Éric Bruckert · 2021 · Biochimie
  56. A zebrafish model for COVID-19 recapitulates olfactory and cardiovascular pathophysiologies caused by SARS-CoV-2
    Aurora Kraus, Elisa Casadei, Mar Huertas, Chunyan Ye, Steven B. Bradfute, Pierre Boudinot, Jean‐Pierre Levraud, Irene Salinas · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  57. A pedestrian-based model for simulating COVID-19 transmission on college campus
    Chuanyao Li, Jie Yin · 2021 · Transportmetrica A Transport Science
  58. Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
    Jia‐You Fang, Kuo‐Yen Huang, Tong‐Hong Wang, Zih‐Chan Lin, Chih‐Cheng Chen, Sui-Yuan Chang, En-Li Chen, Tai-Ling Chao, Shuenn‐Chen Yang, Pan-Chyr Yang et al. · 2024 · Journal of Nanobiotechnology
  59. Wireless breathable face mask sensor for spatiotemporal 2D respiration profiling and respiratory diagnosis
    Jae Hyun Kim, Heesung Roh, Sungmin Moon, Cheonhoo Jeon, Seunggoo Baek, Woo‐Sung Cho, Jae‐Yoon Sim, Unyong Jeong · 2024 · Biomaterials
  60. While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?
    Francisco José Barrantes · 2020 · Frontiers in Physiology
  61. Repurposing CD8 + T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
    Shashi Ashok Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer · 2020 · OncoImmunology
  62. Occupational COVID‐19 risk to dental staff working in a public dental unit in the outbreak epicenter
    Michele Nardone, Angelo Cordone, Stefano Petti · 2020 · Oral Diseases
  63. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery
    Alice Maria Giani, Shuibing Chen · 2021 · Stem Cell Research
  64. SARS-CoV-2 at the human-animal interface: A review
    Elmoubasher Farag, Md. Mazharul Islam, Khalid A Enan, Abdelrahim Mohamed Elhussein, Devendra Bansal, Mohamed Anis Haroun · 2021 · Heliyon
  65. Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats
    Olivia M. Patania, Shiho Chiba, Peter Halfmann, Masato Hatta, Tadashi Maemura, Kristen A. Bernard, Yoshihiro Kawaoka, LaTasha K. Crawford · 2021 · Veterinary Pathology
  66. Structural Bases of Zoonotic and Zooanthroponotic Transmission of SARS-CoV-2
    Emily Clayton, Jacob Ackerley, Marianne Aelmans, Noor Azly Mohamed Ali, Zoe Ashcroft, Clara Ashton, Robert Barker, Vakare Budryte, Callum Burrows, Shanshan Cai et al. · 2022 · Viruses
  67. SARS-CoV-2 Droplet and Airborne Transmission Heterogeneity
    Marta Baselga, A. Güemes, J. Alba, A. J. Schuhmacher · 2022 · Journal of Clinical Medicine
  68. Proactive vs. reactive country responses to the COVID-19 pandemic shock
    Pier Luigi Sacco, Francesco Valle, Manlio De Domenico · 2023 · PLOS Global Public Health
  69. SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review
    Antonio Santaniello, Giuseppe Perruolo, Serena Cristiano, Ayewa Lawoe Agognon, Serena Cabaro, Alessia Amato, Ludovico Dipineto, Luca Borrelli, Pietro Formisano, Alessandro Fioretti et al. · 2023 · Microorganisms
  70. Expression of ACE2 , the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells
    Hanbing Song, Bobak Seddighzadeh, Matthew R. Cooperberg, Franklin W. Huang · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  71. SARS-CoV-2 Transmission, the Ambiguous Role of Children and Considerations for the Reopening of Schools in the Fall
    Cleo G. Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris · 2020 · Future Microbiology
  72. A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an AAV hACE2 Mouse Model and non-human primates
    Farshad Guirakhoo, Lucy Kuo, James Peng, Juin-Hua Huang, Be-Shen Kuo, Feng Lin, Yaw-Jen Liu, Zhi Liu, Grace Wu, Shuang Ding et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
    K. Watashi · 2020 · Biochemical and Biophysical Research Communications - BBRC
  74. Involvement of the STING signaling in COVID-19
    Ruoxuan Xiao, Ao Zhang · 2022 · Frontiers in Immunology
  75. Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53
    Jonathan D. Lee, Bridget L. Menasché, Maria Mavrikaki, Madison M. Uyemura, Su Min Hong, Nina V. Kozlova, Jin Wei, Mia Madel Alfajaro, Renata B. Filler, Arne M. Müller et al. · 2023 · Cell Reports
  76. A Longitudinal Molecular and Cellular Lung Atlas of Lethal SARS-CoV-2 Infection in K18-hACE2 Transgenic Mice
    Seung-Hoon Choi, Jusung Lee, Suhyeon Kim, Youn Woo Lee, Gi-Cheon Kim, Seung-Min Hong, Se-Hee An, Hyuna Noh, Kyung Eun Kim, Dain On et al. · 2022 · EBioMedicine
  77. SARS-CoV-2 Outbreaks on Mink Farms—A Review of Current Knowledge on Virus Infection, Spread, Spillover, and Containment
    Mohammad Jawad Jahid, Andrew S. Bowman, Jacqueline M. Nolting · 2024 · Viruses
  78. Should we be concerned about COVID‐19 with nonhuman primates?
    Wesley José dos Santos, Lívia Maísa Guiraldi, Simone Baldini Lucheis · 2020 · American Journal of Primatology
  79. Lack of Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spillover in Free-Living Neotropical Non-Human Primates, Brazil
    Lívia Sacchetto, Bárbara Aparecida Chaves, Edson Rodrigues Costa, Aline Souza de Menezes Medeiros, Marcelo Gordo, Danielle Bastos Araújo, Danielle Bruna Leal Oliveira, Ana Paula Betaressi da Silva, Andréia Francesli Negri, Edison Luíz Durigon et al. · 2021 · Viruses
  80. SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD – Possible Implications for Interstitial Fibrosis
    Samuel James Brake, Mathew Suji Eapen, Kielan Darcy McAlinden, James Markos, Greg Haug, Josie Larby, Collin Chia, Ashutosh Hardikar, Gurpreet Kaur Singhera, Tillie L Hackett et al. · 2022 · International Journal of COPD
  81. Zebrafish-based platform for emerging bio-contaminants and virus inactivation research
    Paritosh Patel, Aditya Nandi, Suresh K. Verma, Neha Kaushik, Mrutyunjay Suar, Eun Ha Choi, Nagendra Kumar Kaushik · 2023 · The Science of The Total Environment
  82. Analysis and Annotation of DNA Methylation in Two Nonhuman Primate Species Using the Infinium Human Methylation 450K and EPIC BeadChips
    Fabien Pichon, Yimin Shen, Florence Busato, Simon P. Jochems, Béatrice Jacquelin, Roger Le Grand, Jean‐François Deleuze, Michaela C. Müller-Trutwin, Jörg Tost · 2021 · Epigenomics
  83. “Acute Respiratory Distress and Cytokine Storm in Aged, SARS-CoV-2 Infected African Green Monkeys, but not in Rhesus Macaques”
    Robert V. Blair, Monica Vaccari, Lara A. Doyle‐Meyers, Chad J. Roy, Kasi Russell‐Lodrigue, Marissa D. Fahlberg, Chris J. Monjure, Brandon J. Beddingfield, Kenneth S. Plante, Jessica A. Plante et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Nanotechnology of inhalable vaccines for enhancing mucosal immunity
    Qin Li, Yanhua Sun, Nan Gao, Guixia Ling, Peng Zhang · 2023 · Drug Delivery and Translational Research
  85. Zebrafish as a Translational Model: An Experimental Alternative to Study the Mechanisms Involved in Anosmia and Possible Neurodegenerative Aspects of COVID-19?
    Karla Cristinne Mancini Costa, Tamires Amabile Valim Brigante, Gabriel Gripp Fernandes, Davi S. Scomparin, Franciele Franco Scarante, Danielle Palma de Oliveira, Alline Cristina Campos · 2021 · eNeuro
  86. Mitigating COVID-19 Transmission in Schools With Digital Contact Tracing
    Hao-Chen Sun, Xiao Fan Liu, Zhanwei Du, Xiao-Ke Xu, Ye Wu · 2021 · IEEE Transactions on Computational Social Systems
  87. Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia
    Anas A. Khan, Ahmed Alahmari, Yasir S. Almuzaini, Fahad Abdulrahman Alamri, ‏Yousef Alsofayan, Alhanouf Aburas, Saleh Al‐Muhsen, Maria D. Van Kerkhove, Saber Yezli, Gregory R. Ciottone et al. · 2021 · Frontiers in Immunology
  88. Construction of a new chromosome-scale, long-read reference genome assembly for the Syrian hamster, Mesocricetus auratus
    R. Harris, M. Raveendran, Dustin T. Lyfoung, F. Sedlazeck, M. Mahmoud, T. Prall, J. Karl, H. Doddapaneni, Q. Meng, Yi Han et al. · 2021 · bioRxiv
  89. SARS-CoV-2 antibodies in dogs and cats in a highly infected area of Brazil during the pandemic
    Samar Afif Jarrah, Louise Bach Kmetiuk, Fabrizia Valleriani, Barbara Bonfini, Alessio Lorusso, Violetta Iris Vasinioti, Nicola Decaro, Marco Tulio dos Santos, Kledir Anderson Hofstaetter Spohr, Annamaria Pratelli et al. · 2023 · Frontiers in Veterinary Science
  90. An Internet of Things Paradigm: Pandemic Management (incl. COVID-19)
    S Vishnu, S. R. Jino Ramson · 2021 · International Conference on Artificial Intelligence and Smart Energy (ICAIS)
  91. COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells
    Wenzhong Liu, Li hualan · 2021 · Immunologic Research
  92. Optimisation of Non-Pharmaceutical Measures in COVID-19 Growth via Neural Networks
    Annalisa Riccardi, Jessica Gemignani, Francisco Fernández‐Navarro, Anna Heffernan · 2021 · IEEE Transactions on Emerging Topics in Computational Intelligence
  93. Temporal Patterns of COVID-19-Associated Pulmonary Pathology: An Autopsy Study
    George S Stoyanov, Nevena Yanulova, Lyuben Stoev, Nedyalka Zgurova, Viktoriya Mihaylova, Deyan L. Dzhenkov, Martina G Stoeva, Nadezhda Stefanovа, Kalin Kalchev, Lilyana Petkova · 2021 · Cureus
  94. Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
    Natalie M. Kirk, Yu-Ying Liang, H. Ly · 2024 · Virulence
  95. Interplay between respiratory viruses and cilia in the airways
    Katie L. Horton, Peter A. C. Wing, Claire L. Jackson, Christopher J. McCormick, Mary P. Carroll, Jane S. Lucas · 2025 · European Respiratory Review
  96. Early events in hepatitis B infection: the role of inoculum dose
    Stanca M. Ciupe, Naveen K. Vaidya, Jonathan E. Forde · 2021 · Proceedings of the Royal Society B Biological Sciences
  97. Animal Transmission of SARS-CoV-2 and the Welfare of Animals during the COVID-19 Pandemic
    Kimberly Ekstrand, Amanda J. Flanagan, Ilyan E. Lin, Brendon Vejseli, Allicyn Cole, Anna P. Lally, Robert L. Morris, Kathleen N. Morgan · 2021 · Animals
  98. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
    T. Nomura, Hiroyuki Yamamoto, M. Nishizawa, T. Hau, S. Harada, Hiroshi Ishii, Sayuri Seki, Midori Nakamura-Hoshi, Midori Okazaki, Sachie Daigen et al. · 2021 · bioRxiv
  99. Diabetes in COVID-19 patients: challenges and possible management strategies
    Riyan Al Islam Reshad, Sumaiya Hafiz Riana, Mohammad Al-baruni Chowdhury, Abu Tayab Moin, Faruque Miah, Bishajit Sarkar, Nurnabi Azad Jewel · 2021 · Egyptian Journal of Bronchology
  100. Shedding light on the toxicity of SARS-CoV-2-derived peptide in non-target COVID-19 organisms: A study involving inbred and outbred mice
    Thiarlen Marinho da Luz, Amanda Pereira da Costa Araújo, Fernanda Neves Estrela, Abner Marcelino Silva, Ives Charlie‐Silva, Helyson Lucas Bezerra Braz, Paulo Ricardo da Silva Sanches, Md. Mostafizur Rahman, ‪Damià Barceló, Guilherme Malafaia · 2022 · NeuroToxicology